📈SEC Notice on Regulatory Responsibilities Allocation Between FINRA and GIX
The SEC publishes a notice regarding a proposed regulatory responsibility allocation plan between FINRA and Green Impact Exchange, LLC (GIX). The plan seeks to alleviate regulatory redundancies for firms that are members of both organizations, specifically addressing compliance with rules and regulations to enhance operational efficiency and oversight.
Learn More🌍Combined Notice of Filings for Natural Gas Pipeline Rates
The notice from the Department of Energy outlines recent filings regarding natural gas pipeline rates and amendments. Key details include the applicants, effective dates, and comment periods, informing stakeholders of the regulatory landscape and opportunities for public engagement in the processes.
Learn More🐻New Regs for Polar Bear Protection Affecting Oil and Gas Operations
We, the U.S. Fish and Wildlife Service, are revising a portion of our regulations under the Marine Mammal Protection Act pertaining to incidental take of marine mammals. These regulations, codified at 50 CFR part 18, subpart J, authorize the nonlethal, incidental, unintentional take by harassment of small numbers of polar bears from the Southern Beaufort Sea stock and Pacific walruses during year-round oil and gas industry activities in the Beaufort Sea (Alaska and the Outer Continental Shelf) and adjacent northern coast of Alaska. Such take may result from oil and gas exploration, development, production, and transportation activities occurring through August 5, 2026. The revisions made by this final rule authorize incidental Level A harassment of polar bears in addition to the incidental Level B harassment of polar bears and Pacific walruses already authorized. No lethal take is authorized under this rule.
Learn More🏥Unique Device Identifier Requirements for Combination Products
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry and FDA staff entitled "Unique Device Identifier (UDI) Requirements for Combination Products." This draft guidance is intended to assist industry and FDA staff in understanding how FDA's unique device identifier (UDI) requirements apply to combination products with device constituent parts.
Learn More⚕️FDA Modifications to Recognized Standards on Medical Devices
The Food and Drug Administration (FDA or the Agency) is announcing a publication containing modifications the Agency is making to the list of standards FDA recognizes for use in premarket reviews (FDA Recognized Consensus Standards). This publication, entitled "Modifications to the List of Recognized Standards, Recognition List Number: 064" (Recognition List Number: 064), will assist manufacturers who elect to declare conformity with consensus standards to meet certain requirements for medical devices.
Learn More⏳American Time Use Survey
The Department of Labor (DOL) is submitting this Bureau of Labor Statistics (BLS)-sponsored information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). Public comments on the ICR are invited.
Learn More⚡Combined Notice of Filings and Electric Corporate Regulatory Updates
The Department of Energy's Combined Notice of Filings documents a series of electric corporate filings and compliance submissions to the Federal Energy Regulatory Commission. It highlights joint applications, tariff amendments, and comment deadlines, ensuring transparency and public participation in regulatory processes affecting the energy sector.
Learn More💊FDA Announces Regulatory Review Period and Patent Extension for AGAMREE
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for AGAMREE and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.
Learn More📄Proposal for TSCA Confidential Business Information Access Renewal
In compliance with the Paperwork Reduction Act (PRA), this document announces the availability of and solicits public comment on the following Information Collection Request (ICR) that EPA is planning to submit to the Office of Management and Budget (OMB): Request for Contractor Access to TSCA Confidential Business Information (CBI) (EPA ICR No. 1250.13 and OMB Control No. 2070-0075). This ICR represents a renewal of an existing ICR that is currently approved through April 30, 2026. Before submitting the ICR to OMB for review and approval under the PRA, EPA is soliciting comments on specific aspects of the information collection that is summarized in this document. The ICR and accompanying material are available in the docket for public review and comment.
Learn More💰Natural Gas Pipeline Rate Filings and Compliance Updates
The Department of Energy's regulatory notice details multiple Natural Gas Pipeline Rate and Refund Report filings, along with opportunities for public comment and intervention. It specifies applicants, filing descriptions, and effective dates, while also providing guidance for engaging in proceedings to ensure stakeholder participation in regulatory processes.
Learn More